{"id":"https://genegraph.clinicalgenome.org/r/ca78c869-d67c-40c8-8c70-fcc52a4d4744v1.1","type":"EvidenceStrengthAssertion","dc:description":"Heterozygous variants in the fumarate hydratase (FH) gene are associated with the autosomal dominant disorder hereditary leiomyomatosis and renal cell cancer (HLRCC). This was first proposed by Tomlinson et al in 2002 (PMID: 11865300). Numerous genetic studies have reported familial segregation of FH variants in families with leiomyomatosis or renal cell cancer. Affected individuals with heterozygous mutations had decreased fumarate hydratase enzyme activity in their lymphoblastoid cell lines although penetrance varies among individuals with similar decreases in FH activity. Tumors from HLRCC patients with a FH germline heterozygous mutations presented markedly reduced enzyme activity due to a second hit on FH, compared with tumors with similar histology from non HLRCC patients. There are substantial other functional assays demonstrating deficiency of FH activity and abnormality in smooth muscle differentiation. In summary, FH is definitively associated with HLRCC. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/ca78c869-d67c-40c8-8c70-fcc52a4d4744","GCISnapshot":"https://genegraph.clinicalgenome.org/r/59e42ccd-2b0b-441c-8529-6eb1e9dde330","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/59e42ccd-2b0b-441c-8529-6eb1e9dde330_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-16T19:22:58.226Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/59e42ccd-2b0b-441c-8529-6eb1e9dde330_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-05-14T00:23:34.007Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59e42ccd-2b0b-441c-8529-6eb1e9dde330_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59e42ccd-2b0b-441c-8529-6eb1e9dde330_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cabeda10-e52c-40f8-8472-008e00cea7d9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a7decbd5-46db-4d75-934c-4620219f1dc7","type":"Finding","dc:description":"1. FH enzyme activity in patients' whole lymphoblastoid cells or fibroblasts was significantly lower than that of normal control.\n2. FH enzyme activity in the lymphoblastoid cell lines of patients with other hereditary renal cancer syndromes has no difference from normal control\n3. FH enzyme activity in the blood sample of the normal siblings of patients has no difference from normal control.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16597677","rdfs:label":"spectrophotometric assay for fumarate hydratase activity","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/59e42ccd-2b0b-441c-8529-6eb1e9dde330_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ec6650c-401c-4db1-aa08-db85a491e30e","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e8b6c23-5d31-4b0e-a536-3f1e30fb7109","type":"FunctionalAlteration","dc:description":"FH-deficiency fibroblast cells and leiomyomas showed down-regulation of serum response factor (SRF)signaling, which has a key function in smooth muscle differentiation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22014577","rdfs:label":"Down-regulation of serum response factor (SRF)"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f84d9fd4-c3c3-47fa-b624-4b513e2dce4b","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c4922d9-c719-47f8-9b01-77e67e2add2b","type":"FunctionalAlteration","dc:description":"FH expression appears somewhat decreased in UOK 262 compared to 786-O and HK-2 renal\ncells by real time PCR.  Western blotting confirms that the expressed FH protein is full-length.The enzymatic activity of FH protein in UOK 262 cells is not detectable, and is at least 60-fold lower than in either 786-O or HK-2 cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19963135","rdfs:label":"In vitro FH enzyme activity"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8a2effef-a31d-415f-8906-7ff8e6012587","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2070579-009c-43bf-9d9c-9c7b45f71eda","type":"FunctionalAlteration","dc:description":"All tumors showed greatly reduced activity (indistinguishable from zero) relative to overlying normal (heterozygous) skin, which is consistent with a loss or severe reduction in concentrations of fumarate hydratase, as predicted.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11865300","rdfs:label":"enzyme activity of fumarate hydratase in skin leiomyomata"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/59e42ccd-2b0b-441c-8529-6eb1e9dde330_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7cd3d53-c759-436a-8d8b-ea08883a386b","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/21014986-f49b-460d-b85c-3ddc3b0092de","type":"Finding","dc:description":"1. FH transfections substantially corrected the fumarate accumulation that was observed in Fh1-/- cells (Fig. 3B).\n2. the introduction of full-length FH into Fh1-/- cells restored respiration to wild-type\nlevels\n3. FH  transfections corrected the upregulation of HIF- target genes transcript levels in normoxic Fh1-/- MEFs. (Fig. 4b)  [FH-associated human tumors display upregulation of\nhypoxia-inducible factor].","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20660115","rdfs:label":"re-expression of FH in FH-/- cell","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5},{"id":"https://genegraph.clinicalgenome.org/r/59e42ccd-2b0b-441c-8529-6eb1e9dde330_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59e42ccd-2b0b-441c-8529-6eb1e9dde330_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/328f91c2-3fb4-486a-8ba1-f420216d31fa_proband_segregation","type":"FamilyCosegregation","dc:description":"Only three affected members","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26493120","rdfs:label":"A family with three sisters having large uterine myomas","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/328f91c2-3fb4-486a-8ba1-f420216d31fa","type":"Family","rdfs:label":"A family with three sisters having large uterine myomas","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/5749186a-6b51-4e09-833f-202d485fcd2e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26493120","rdfs:label":"III:1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":27,"detectionMethod":"The proband had All exons of FH gene Sanger sequenced. Father and one affected siblings only have targeted sequence.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Cutaneous leiomyomas, many <1-cm uterous fibroids that could not be removed. The patient's pathology showed more diffuse cytologic atypia, but there was no\nmitotic activity or necrosis","phenotypes":["obo:HP_0000131","obo:HP_0007620"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/487ab212-aaf6-4778-8e5a-159b143cd187_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26493120","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c14e250-8176-4df3-966f-a75267604afe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000143.3(FH):c.295_301delTTGAAGC (p.Leu99Glufs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/214435"}}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Cutaneous leiomyomas, many <1-cm uterous fibroids that could not be removed. The patient's pathology showed more diffuse cytologic atypia, but there was no\nmitotic activity or necrosis","phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0000131","obo:HP_0007620"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/5749186a-6b51-4e09-833f-202d485fcd2e"}},{"id":"https://genegraph.clinicalgenome.org/r/21032f88-0ef8-4e53-9223-2f98ae3969aa_proband_segregation","type":"FamilyCosegregation","dc:description":"There was not specific information saying all the symptomatic family members carried this familial variant. II:5 here was reported as asymptomatic in PMID 22086304 (II:4).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22086304","rdfs:label":"a Dutch HLRCC family","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/21032f88-0ef8-4e53-9223-2f98ae3969aa","type":"Family","rdfs:label":"a Dutch HLRCC family","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/dbf89424-452d-49c6-a0c3-72220ca0bb99","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22086304","rdfs:label":"III:4","ageType":"AgeAtReport","ageUnit":"Years","ageValue":18,"detectionMethod":"polymerase chain reaction (PCR) the coding regions and exonâ€”intron boundaries of the FH gene","firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0005584","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3d5803fc-c349-4a02-bfb7-b26e7465e812_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22086304","allele":{"id":"https://genegraph.clinicalgenome.org/r/b012eeae-57c1-4ecd-95f4-41cdebf92aaa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000143.3(FH):c.1000A>C (p.Ser334Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/142077"}}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0005584","obo:HP_0007620","obo:HP_0000131"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/dbf89424-452d-49c6-a0c3-72220ca0bb99"}},{"id":"https://genegraph.clinicalgenome.org/r/1690d79b-8e9b-4c1b-a74e-2bc7236d7eec_proband_segregation","type":"FamilyCosegregation","dc:description":"PMID: 11982768 ,  LOD score  4.453 generated by microsatellite linkage analysis. \n\n>10 affected members, and 10 affected members shared same haplotype","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14632190","rdfs:label":"MCL-1","family":{"id":"https://genegraph.clinicalgenome.org/r/1690d79b-8e9b-4c1b-a74e-2bc7236d7eec","type":"Family","rdfs:label":"MCL-1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/a2a1d9ce-cee4-4753-9bf4-2ce40a6a1fda","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14632190","rdfs:label":"IV-3","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sanger all exons and splice junction of FH gene","firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0007620","previousTesting":true,"previousTestingDescription":"Multipoint analysis supported linkage to this region, with a maximum multipoint LOD score of 4.453 throughout the interval D1S2785-D1S1609.\n\nMicrosatellite PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/89f7e634-6bcd-4497-9dc3-ca931fe042d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14632190","allele":{"id":"https://genegraph.clinicalgenome.org/r/c01cc4d4-da9a-44fc-84e9-494fe37b6cad","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000143.3(FH):c.952C>T (p.His318Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/92458"}}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":10,"phenotypes":["obo:HP_0007620","obo:HP_0000131"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/a2a1d9ce-cee4-4753-9bf4-2ce40a6a1fda"},"publishedLodScore":4.453,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/20cd7469-60e7-4aa2-a4f4-ec176a4a2bd7_proband_segregation","type":"FamilyCosegregation","dc:description":"Four segregation. \nFive affected patients all had positive genotype.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20618355","rdfs:label":"LMY26","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/20cd7469-60e7-4aa2-a4f4-ec176a4a2bd7","type":"Family","rdfs:label":"LMY26","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/3fb3cb57-d9fc-4901-8c21-421b6f3fdc59","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20618355","rdfs:label":"III:11","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"All exons of the FH gene (accession number NM000143.2) and flanking intron sequences were amplified by polymerase chain reaction (PCR). \nThe DNA samples from mutation-negative patients were screened for exon deletions and/or duplications of the FH gene by MLPA analysis\nHaplotypes were determined by analysis of microsatellite markers surrounding FH for available family members with a common FH mutation","firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0007620","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Genotyping","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c001e18b-26ff-48aa-a680-cff6a2a34e43_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20618355","allele":{"id":"https://genegraph.clinicalgenome.org/r/6ab43030-ff30-4bb3-847c-1d6e5e681952","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000001.11:g.241506083C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345438949"}}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0000131","obo:HP_0007620"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/3fb3cb57-d9fc-4901-8c21-421b6f3fdc59"}},{"id":"https://genegraph.clinicalgenome.org/r/b7019387-1f65-4749-beda-8c85d86753e9_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14632190","rdfs:label":"MCL-2","family":{"id":"https://genegraph.clinicalgenome.org/r/b7019387-1f65-4749-beda-8c85d86753e9","type":"Family","rdfs:label":"MCL-2","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ac4a099a-22ba-4e19-bec9-8b57facbdb18","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14632190","rdfs:label":"II-1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Directly sequencing all the exons of FH gene","firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0007620","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b5ecb7b0-44b3-434e-a9af-6d0b5f952e43_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14632190","allele":{"id":"https://genegraph.clinicalgenome.org/r/c65eeb98-960f-4eb9-8ac7-139869cbcd34","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000143.3(FH):c.424C>T (p.Gln142Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/644761"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"phenotypeFreeText":"","phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0007620","proband":{"id":"https://genegraph.clinicalgenome.org/r/ac4a099a-22ba-4e19-bec9-8b57facbdb18"}},{"id":"https://genegraph.clinicalgenome.org/r/92a65210-02eb-4fc6-b931-366f032845c5_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11865300","rdfs:label":"UK Family 304","estimatedLodScore":4.21,"family":{"id":"https://genegraph.clinicalgenome.org/r/92a65210-02eb-4fc6-b931-366f032845c5","type":"Family","rdfs:label":"UK Family 304","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/11bd46db-ab93-4b86-89ec-742c85f8108d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11865300","rdfs:label":"IV:3","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Use PCR to screen 6 known genes and over 50 predicted gene or transcripts  in the critical region. Putative pathogenic sequence changes only detected in FH gene by Sanger.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000131","obo:HP_0007620"],"previousTesting":true,"previousTestingDescription":"Use STR sequence to map a 1.6 Mb critical region covering the multiple leiomyomatosis gene","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/cf9e3f4f-7f4b-4740-994b-bb3e2b1984c6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11865300","allele":{"id":"https://genegraph.clinicalgenome.org/r/5ddd87eb-b654-40c2-87ca-253f126ed8de","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000143.3(FH):c.320A>C (p.Asn107Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/92455"}}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Cutaneous leiomyomas, Uterine fibroid, renal cell cancer","phenotypePositiveAllelePositive":15,"phenotypes":["obo:HP_0007620","obo:HP_0000131"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/11bd46db-ab93-4b86-89ec-742c85f8108d"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/1ec603e1-2667-42f6-a17f-30fc94c4eb6d_proband_segregation","type":"FamilyCosegregation","dc:description":"Three generation, 7 affected patient with positive genotype.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20618355","rdfs:label":"LMY05","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/1ec603e1-2667-42f6-a17f-30fc94c4eb6d","type":"Family","rdfs:label":"LMY05","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/e79c6ec0-0ca5-4778-adf3-051a374d2130","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20618355","rdfs:label":"III:9","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"All exons of the FH gene (NM 000143.2) and flanking intron sequences were amplified by polymerase chain reaction (PCR). \nThe DNA samples from mutation-negative patients were screened for exon deletions and/or duplications of the FH gene by MLPA analysis","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000131","obo:HP_0007620","obo:HP_0005584"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Genotyping","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e5a3ae17-0782-49a3-b35b-e7834cf5a9a0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20618355","allele":{"id":"https://genegraph.clinicalgenome.org/r/e0b65133-9d30-43b6-ae66-0eec3cf43565","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000143.3(FH):c.1189G>A (p.Gly397Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/214422"}}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":7,"phenotypes":["obo:HP_0005584","obo:HP_0007620","obo:HP_0000131"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e79c6ec0-0ca5-4778-adf3-051a374d2130"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/59e42ccd-2b0b-441c-8529-6eb1e9dde330_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bfb2521a-b1aa-46e9-a512-d13c37272a8c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A heterzgyous missense c.1021G>A (p.Asp341Asn) on the FH gene. His eldest son, 38 yr, who carried this variant and asymptomatic, turned out to have pathological papillary renal cell carcinoma type 2 after asking for extensive testing. No functional study about this variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3474c1a3-fb2e-4944-9552-c4b022c85c58","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24684806","rdfs:label":"Case 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":64,"detectionMethod":"directly sequenced all coding exons of the FH gene","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0006732","previousTesting":true,"previousTestingDescription":"Directly sequenced all coding exons of VHL and FH gene in the peripheral blood leukocyte, but no mutation was detected in VHL","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/bfb2521a-b1aa-46e9-a512-d13c37272a8c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24684806","allele":{"id":"https://genegraph.clinicalgenome.org/r/b68b99a3-78a2-41fa-960c-2e5e6fddd7c7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000143.3(FH):c.1021G>A (p.Asp341Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/405923"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/3d5803fc-c349-4a02-bfb7-b26e7465e812_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A heterozygous missense c.1000A>C (p.Ser334Arg) without functional evaluation","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dbf89424-452d-49c6-a0c3-72220ca0bb99"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/89f7e634-6bcd-4497-9dc3-ca931fe042d2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A heterzgyous missnsen c.952C>T (p.His318Tyr) on the FH gene was segregated in a big family with 5 generations and multiple affected members.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a2a1d9ce-cee4-4753-9bf4-2ce40a6a1fda"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e5a3ae17-0782-49a3-b35b-e7834cf5a9a0_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The author didn't provide any functional evidence for this missense change. But in PMID:21398687, two heterozygous carriers of the G397R variant showed a significantly decreased fumarate hydratase enzyme activity in  their lymphoblastoid cell lines. Still stay 0.5 point.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e79c6ec0-0ca5-4778-adf3-051a374d2130"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c001e18b-26ff-48aa-a680-cff6a2a34e43_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A heterozygous missense c.824G>A (p.Gly275Glu) was segregated in the families with multiple affected members.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3fb3cb57-d9fc-4901-8c21-421b6f3fdc59"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/cf9e3f4f-7f4b-4740-994b-bb3e2b1984c6_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The activity of fumarate hydratase in lymphoblastoid lines from proband with  a heterzgyous missense c.320A>C (p.Asn107Thr) mutation was half of the control","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11bd46db-ab93-4b86-89ec-742c85f8108d"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c1c165f0-0370-4f94-9fd8-be44ec372099_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Enzymatic assays showed patient tumor very low levels of FH activity in comparison to a panel of clear-cell RCC tumors(Figure 3b).\nThe introduction of wild-type FH into  pRCC-2-derived UOK262 cells restores the formation of normal-sized tetrameric complexes, whereas the introduction of FH Asp341Asn fails to restore normal-sized complexes(Figure 4c).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68335235-9ca9-472e-bfa5-40325e4dde97","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21304509","rdfs:label":"24-year-old woman","ageType":"AgeAtReport","ageUnit":"Years","ageValue":24,"detectionMethod":"Sequencing analyses of DNA from peripheral blood mononuclear cells showed a heterozygous germline FH mutation. Patient tumor presented typically exhibit loss of heterozygosity.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"uterine fibroids, renal cystic mass most consistent with a type-2 papillary renal cell carcinoma.","phenotypes":["obo:HP_0006732","obo:HP_0000131"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/c1c165f0-0370-4f94-9fd8-be44ec372099_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21304509","allele":{"id":"https://genegraph.clinicalgenome.org/r/b68b99a3-78a2-41fa-960c-2e5e6fddd7c7"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/59e42ccd-2b0b-441c-8529-6eb1e9dde330_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/339734d6-c063-45c3-a2f6-14e3fbc7bdf8_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A nonsense mutation c.301C>T (p.Arg101Ter) was reported in three unrelated families. Functional assay of  fumarate hydratase in the proband's lymphoblastoid line showed decreased to half of the control activity. This variant was considered as a hot spot mutation.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f10af2d-563c-4a16-9c54-c5b623d6bac6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11865300","rdfs:label":"Family 14","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0007620","obo:HP_0000131"],"previousTesting":true,"previousTestingDescription":"Linkage analysis: \nUsing mainly the high-accuracy Sanger Centre BAC contig\nand its associated draft sequence, the authors searched for short tandem\nrepeats between the D1S517 and D1S2842 markers.","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/339734d6-c063-45c3-a2f6-14e3fbc7bdf8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11865300","allele":{"id":"https://genegraph.clinicalgenome.org/r/64dddcdb-d5f9-4e85-bf21-df900d47b9a7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000143.3(FH):c.301C>T (p.Arg101Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16232"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a53d4ac3-6a3c-4462-b993-b98ce6c331a0_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A nonsense c.1027C>T (p.Arg343Ter) was predicted to cause nonsense-mediated mRNA decay.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bec1af2a-605f-458b-bc62-9a83ca61f786","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11865300","rdfs:label":"Family Fin 3","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0007620","obo:HP_0005584","obo:HP_0000131"],"previousTesting":true,"previousTestingDescription":"Linkage analysis: applying STR marker to refine the region of the multiple\nleiomyomatosis gene","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/a53d4ac3-6a3c-4462-b993-b98ce6c331a0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11865300","allele":{"id":"https://genegraph.clinicalgenome.org/r/c42cbedd-e208-4e9e-a1fd-433cc3d8447d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000143.3(FH):c.1027C>T (p.Arg343Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA167294"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/42c8ad4b-ad30-4a72-927a-a1cc7cf1cdbf_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A 2 bps deletion (c.671_672delAG) on the FH gene results in a frameshift mutation and cause premature termination of translation (p.Glu224Valfs).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3757937-84ff-405c-a2e5-effa7e9cc9d8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11865300","rdfs:label":"Family Fin 1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0002891","obo:HP_0006732"],"previousTesting":true,"previousTestingDescription":"Linkage analysis: short tandem repeats between the D1S517 and D1S2842 markers, refining \nthe multiple leiomyomatosis gene within a region of 1.6 Mb between the centromeric end of BAC RP11-25B4 and the telomeric end of RP11-553N16.","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/42c8ad4b-ad30-4a72-927a-a1cc7cf1cdbf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11865300","allele":{"id":"https://genegraph.clinicalgenome.org/r/8500e0da-ef95-49c9-9c51-1f40944fffcb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000143.3(FH):c.671_672delAG (p.Glu224Valfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA257458"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b5ecb7b0-44b3-434e-a9af-6d0b5f952e43_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A nonsense c.424C>T (p.Gln142Ter) on the exon 4 of FH gene was predicted to cause a truncated protein","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac4a099a-22ba-4e19-bec9-8b57facbdb18"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/487ab212-aaf6-4778-8e5a-159b143cd187_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A 7 bp deleiton c.295_301delTTGAAGC (p.Leu99Glufs) on the FH gene was predicted to cause premature termination of translation and result in a truncated protein.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5749186a-6b51-4e09-833f-202d485fcd2e"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":7.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":745,"specifiedBy":"GeneValidityCriteria7","strengthScore":15.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/K2Bb90oBRQo","type":"GeneValidityProposition","disease":"obo:MONDO_0007888","gene":"hgnc:3700","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_59e42ccd-2b0b-441c-8529-6eb1e9dde330-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}